|4Jan 6, 8:25 PM ET

aTYR PHARMA INC 4

4 · aTYR PHARMA INC · Filed Jan 6, 2016

Insider Transaction Report

Form 4
Period: 2016-01-04
Blackburn Stan
Acting Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2016-01-04+5,7545,754 total
    Exercise: $9.13Common Stock (5,754 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall vest and become exercisable, if at all, in 48 equal monthly installments upon the achievement of certain performance goals, which must be achieved by January 4, 2018, or such option will be subject to immediate forfeiture. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION